This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Genon Laboratories Ltd
Genon Laboratories Ltd, commonly referred to as Genon Labs, is a leading player in the pharmaceutical and biotechnology industry, headquartered in Great Britain. Founded in 2005, the company has established a strong presence in key operational regions across Europe and North America, focusing on innovative solutions in drug development and manufacturing. Specialising in high-quality active pharmaceutical ingredients (APIs) and advanced drug delivery systems, Genon Labs is recognised for its commitment to research and development, ensuring that its products meet the highest industry standards. The company has achieved significant milestones, including several successful partnerships with major pharmaceutical firms, solidifying its market position as a trusted provider of cutting-edge solutions. With a dedication to excellence and innovation, Genon Laboratories Ltd continues to make strides in enhancing healthcare outcomes globally.
DitchCarbon Score
How does Genon Laboratories Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genon Laboratories Ltd's score of 66 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Genon Laboratories Ltd, headquartered in Great Britain, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of SYNLAB AG, which influences its climate commitments and emissions reporting. As part of its corporate family relationship, Genon Laboratories Ltd inherits emissions data and reduction initiatives from SYNLAB AG. However, there are no documented reduction targets or specific climate pledges outlined for Genon Laboratories Ltd at this time. The absence of direct emissions data and reduction targets suggests that the company may still be in the process of establishing its own climate strategy or aligning with the broader initiatives of its parent organization. As the industry increasingly focuses on sustainability, it is essential for Genon Laboratories Ltd to develop and communicate its climate commitments to meet stakeholder expectations and regulatory requirements.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 22,155,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 16,535,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Genon Laboratories Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
